COVID-19: MSN Laboratories initiates Phase III clinical trial of Molnupiravir

May 26, 2021

New Delhi [India], May 26 : MSN Laboratories Private Limited (MSN) is initiating phase III clinical trial of Molnupiravir capsules for the treatment of...

Optimus announces Interim Clinical Results from Phase III Clinical Trials of Molnupiravir conducted in India

Jul 21, 2021

Hyderabad (Telangana) [India], July 21 (ANI/PNN): Optimus Pharma on Sunday submitted the interim result of Phase III Clinical Trials for orally administered Molnupiravir capsules...

Dr Reddy's laboratories gets DCGI's nod to launch Molnupiravir capsules in India

Dec 28, 2021

Hyderabad (Telangana) [India], December 28 : Drugs Controller General of India (DCGI) on Tuesday approved Dr Reddy's laboratories for the emergency-use authorisation) to manufacture...

Drugs manufacturer from Hyderabad on overdrive

May 19, 2021

Hyderabad (Telangana) [India], May 19 (ANI/PNN): Optimus Pharma on Tuesday received DCGI nod for conducting Phase III Clinical Trials for orally administered Molnupiravir capsules...

Optimus Pharma gets DCGI nod for conducting Phase III Clinical Trials for Molnupiravir on patients with mild to moderate COVID-19

May 25, 2021

Hyderabad (Telangana) [India], May 25 (ANI/PRNewswire): Optimus Pharma on the 19th of May 2021 received DCGI nod for conducting Phase III Clinical Trials for...

COVID-19: Oral anti-viral drug Molnupiravir is not included in national task treatment, says ICMR chief Dr. Bhargava

Jan 05, 2022

New Delhi [India], January 5 : Indian Council of Medical Research (ICMR) head Dr. Balram Bhargava on Wednesday stated that the oral anti-viral drug...